chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pruritus, Vaccination site erythema, Vaccination site pruritus, Vaccination site reaction
Clinical narrative: arm is about 2inches diameter; itchy, itchy, itchy; redness and itchiness around the injection site; redness and itchiness around the injection site; soreness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (redness and itchiness around the injection site), VACCINATION SITE PRURITUS (redness and itchiness around the injection site), VACCINATION SITE REACTION (arm is about 2inches diameter), PAIN (soreness) and PRURITUS (itchy, itchy, itchy) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (redness and itchiness around the injection site), VACCINATION SITE PRURITUS (redness and itchiness around the injection site) and PAIN (soreness). On 22-Jan-2021, the patient experienced VACCINATION SITE REACTION (arm is about 2inches diameter) and PRURITUS (itchy, itchy, itchy). The patient was treated with HYDROCORTISONE (topical) in January 2021 for Adverse event, at a dose of UNK dosage form. On 18-Jan-2021, PAIN (soreness) had resolved. At the time of the report, VACCINATION SITE ERYTHEMA (redness and itchiness around the injection site), VACCINATION SITE PRURITUS (redness and itchiness around the injection site), VACCINATION SITE REACTION (arm is about 2inches diameter) and PRURITUS (itchy, itchy, itchy) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication were provided by the reporter.     Most recent FOLLOW-UP information incorporated above includes: On 04-May-2021: outcome of events changed to resolved
Sex: M
Vaccine: COVID19
Symptoms: Nasal congestion, Vaccination site pain
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of nasal congestion (congestion in the nasal cavity/didn't have the drainage that I normally have) and vaccination site pain (bruise-type feeling) in an 80-year-old male patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 037K20A) for COVID-19 immunization. No medical history reported. On Jan 18, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On Jan 20, 2021, patient experienced nasal congestion (congestion in the nasal cavity/didn't have the drainage that I normally have). On Jan 21, 2021, patient experienced vaccination site pain (bruise-type feeling). On Jan 22, 2021, vaccination site pain (bruise-type feeling): resolved. At the time of the report, nasal congestion (congestion in the nasal cavity/didn't have the drainage that I normally have) outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown. No concomitant medications or treatment information were provided. Reporter did not allow further contact.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, COVID-19, Dizziness, Headache, Nausea
Clinical narrative: Dizzy; vertigo; Feeling week; Tested positive for Covid-19; Headache; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizzy), VERTIGO (vertigo), ASTHENIA (Feeling week), COVID-19 (Tested positive for Covid-19) and HEADACHE (Headache) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.     On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (Dizzy), VERTIGO (vertigo), ASTHENIA (Feeling week), COVID-19 (Tested positive for Covid-19), HEADACHE (Headache) and NAUSEA (Nausea). At the time of the report, DIZZINESS (Dizzy), VERTIGO (vertigo), ASTHENIA (Feeling week), COVID-19 (Tested positive for Covid-19), HEADACHE (Headache) and NAUSEA (Nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided. No treatment information provided.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Vertigo
Clinical narrative: Dizzy; vertigo; Feeling week; Tested positive for Covid-19; Headache; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizzy), VERTIGO (vertigo), ASTHENIA (Feeling week), COVID-19 (Tested positive for Covid-19) and HEADACHE (Headache) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.     On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (Dizzy), VERTIGO (vertigo), ASTHENIA (Feeling week), COVID-19 (Tested positive for Covid-19), HEADACHE (Headache) and NAUSEA (Nausea). At the time of the report, DIZZINESS (Dizzy), VERTIGO (vertigo), ASTHENIA (Feeling week), COVID-19 (Tested positive for Covid-19), HEADACHE (Headache) and NAUSEA (Nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided. No treatment information provided.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Slight soreness in arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Slight soreness in arm) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012120A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included MULTIVITAMIN [VITAMINS NOS] for an unknown indication.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced VACCINATION SITE PAIN (Slight soreness in arm). At the time of the report, VACCINATION SITE PAIN (Slight soreness in arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Pyrexia, Vaccination site erythema, Vaccination site pain, Vaccination site pruritus
Clinical narrative: Arm hurt; Injection site was swollen; Injection site was itching; Injection site was red, spread out a bit; Low-grade fever; Chills; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Arm hurt), VACCINATION SITE SWELLING (Injection site was swollen), VACCINATION SITE PRURITUS (Injection site was itching), VACCINATION SITE ERYTHEMA (Injection site was red, spread out a bit) and PYREXIA (Low-grade fever) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included ETHINYLESTRADIOL, NORETHISTERONE ACETATE (LOESTRIN) for an unknown indication.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Jan-2021, the patient experienced VACCINATION SITE PAIN (Arm hurt), VACCINATION SITE SWELLING (Injection site was swollen), VACCINATION SITE PRURITUS (Injection site was itching), VACCINATION SITE ERYTHEMA (Injection site was red, spread out a bit), PYREXIA (Low-grade fever) and CHILLS (Chills). At the time of the report, VACCINATION SITE PAIN (Arm hurt), VACCINATION SITE SWELLING (Injection site was swollen), VACCINATION SITE PRURITUS (Injection site was itching), VACCINATION SITE ERYTHEMA (Injection site was red, spread out a bit), PYREXIA (Low-grade fever) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No treatment information provided.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling
Clinical narrative: Arm hurt; Injection site was swollen; Injection site was itching; Injection site was red, spread out a bit; Low-grade fever; Chills; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Arm hurt), VACCINATION SITE SWELLING (Injection site was swollen), VACCINATION SITE PRURITUS (Injection site was itching), VACCINATION SITE ERYTHEMA (Injection site was red, spread out a bit) and PYREXIA (Low-grade fever) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included ETHINYLESTRADIOL, NORETHISTERONE ACETATE (LOESTRIN) for an unknown indication.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Jan-2021, the patient experienced VACCINATION SITE PAIN (Arm hurt), VACCINATION SITE SWELLING (Injection site was swollen), VACCINATION SITE PRURITUS (Injection site was itching), VACCINATION SITE ERYTHEMA (Injection site was red, spread out a bit), PYREXIA (Low-grade fever) and CHILLS (Chills). At the time of the report, VACCINATION SITE PAIN (Arm hurt), VACCINATION SITE SWELLING (Injection site was swollen), VACCINATION SITE PRURITUS (Injection site was itching), VACCINATION SITE ERYTHEMA (Injection site was red, spread out a bit), PYREXIA (Low-grade fever) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No treatment information provided.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test, Electrocardiogram, Hyperhidrosis, Palpitations, Panic attack
Clinical narrative: Panic attack; Heart racing; Hands cold; Sweating; This spontaneous case was reported by a patient and describes the occurrence of PANIC ATTACK (Panic attack), PALPITATIONS (Heart racing), PERIPHERAL COLDNESS (Hands cold) and HYPERHIDROSIS (Sweating) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included ALBUTEROL SULFATE and HYDROXYZINE for an unknown indication.    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2021, the patient experienced PANIC ATTACK (Panic attack), PALPITATIONS (Heart racing), PERIPHERAL COLDNESS (Hands cold) and HYPERHIDROSIS (Sweating). At the time of the report, PANIC ATTACK (Panic attack), PALPITATIONS (Heart racing), PERIPHERAL COLDNESS (Hands cold) and HYPERHIDROSIS (Sweating) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 05-Feb-2021, Blood test: normal (normal) normal. On 05-Feb-2021, Electrocardiogram: normal (normal) normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral coldness
Clinical narrative: Panic attack; Heart racing; Hands cold; Sweating; This spontaneous case was reported by a patient and describes the occurrence of PANIC ATTACK (Panic attack), PALPITATIONS (Heart racing), PERIPHERAL COLDNESS (Hands cold) and HYPERHIDROSIS (Sweating) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included ALBUTEROL SULFATE and HYDROXYZINE for an unknown indication.    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2021, the patient experienced PANIC ATTACK (Panic attack), PALPITATIONS (Heart racing), PERIPHERAL COLDNESS (Hands cold) and HYPERHIDROSIS (Sweating). At the time of the report, PANIC ATTACK (Panic attack), PALPITATIONS (Heart racing), PERIPHERAL COLDNESS (Hands cold) and HYPERHIDROSIS (Sweating) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 05-Feb-2021, Blood test: normal (normal) normal. On 05-Feb-2021, Electrocardiogram: normal (normal) normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: Arm is red, swelling and itching; Arm is red, swelling and itching; Arm is red, swelling and itching; This spontaneous case was reported by a consumer and describes the occurrence of   in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included MULTIVITAMINS [VITAMINS NOS] and CETIRIZINE HYDROCHLORIDE (ZYRTEC ALLERGY) for an unknown indication.    On 20-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided. No treatment information provided.   Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of vaccination site erythema (red circle at the injection site) in a female patient, of an unknown age, who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 026L20A) for COVID-19 immunization. No medical history reported. On an unknown date, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown. On an unknown date, after the mRNA-1273 (Moderna COVID-19 vaccine), patient experienced  vaccination site erythema (red circle at the injection site). At the time of the report, vaccination site erythema (red circle at the injection site) outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown. No concomitant medications and treatment information provided.
Age: 90.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain, Vaccination site pruritus, Vaccination site rash
Clinical narrative: sore arm; itchy spot; red rash about 1 inch above the vaccine site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (itchy spot), VACCINATION SITE RASH (red rash about 1 inch above the vaccine site) and VACCINATION SITE PAIN (sore arm) in a 90-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (itchy spot) and VACCINATION SITE RASH (red rash about 1 inch above the vaccine site). On an unknown date, the patient experienced VACCINATION SITE PAIN (sore arm). At the time of the report, VACCINATION SITE PRURITUS (itchy spot), VACCINATION SITE RASH (red rash about 1 inch above the vaccine site) and VACCINATION SITE PAIN (sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided. No treatment information provided.   Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of rash (developed, 2 different types of rashes) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. On an unknown date, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On an unknown date, patient experienced rash (developed, 2 different types of rashes). At the time of the report, rash (developed, 2 different types of rashes) outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown. No concomitant medications or treatment information provided.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination complication, Vaccination site erythema, Vaccination site pain
Clinical narrative: Delayed Reactions 7-14 days after vaccination; Delayed Onset Pain on the Injection Site; Delayed Onset Redness a little lower than the Injection Site; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of VACCINATION COMPLICATION (Delayed Reactions 7-14 days after vaccination), VACCINATION SITE PAIN (Delayed Onset Pain on the Injection Site) and VACCINATION SITE ERYTHEMA (Delayed Onset Redness a little lower than the Injection Site) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.     In January 2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Delayed Reactions 7-14 days after vaccination), VACCINATION SITE PAIN (Delayed Onset Pain on the Injection Site) and VACCINATION SITE ERYTHEMA (Delayed Onset Redness a little lower than the Injection Site). At the time of the report, VACCINATION COMPLICATION (Delayed Reactions 7-14 days after vaccination), VACCINATION SITE PAIN (Delayed Onset Pain on the Injection Site) and VACCINATION SITE ERYTHEMA (Delayed Onset Redness a little lower than the Injection Site) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided. No treatment information provided.
Sex: F
Vaccine: COVID19
Symptoms: Hordeolum
Clinical narrative: Stye in her eye; Case reference number MOD-2021-012942 is a report which refers to a 66 Years old Female patient.  The patient experienced Stye in her eye.  This occurred while participating in Protocol mRNA-1273 Moderna COVID-19 vaccine   .  The patients started Moderna COVID-19 Vaccine on  .  Some     later, the patient developed Stye.'  Relevant laboratory results were not reported  and relevant physical signs were <LIST PHYSICAL SYMPTOMS>. The patient experienced the following serious criteria:   The eventual diagnosis made was Hordeolum .  The patient was treated for the event with  antibiotic.The action taken for Moderna COVID-19 Vaccine was  Unknown on  . The event(s) were:  Stye in her eye - Unknown.  The investigator considered the Stye in her eye  not related to the drug/placebo.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Dizziness, Headache, Myalgia, Pyrexia
Clinical narrative: Gone down sick; Dizzy; Feels weak; Fever; Headache; Muscle ache; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Gone down sick), DIZZINESS (Dizzy), ASTHENIA (Feels weak), PYREXIA (Fever) and HEADACHE (Headache) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.     On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Gone down sick), DIZZINESS (Dizzy), ASTHENIA (Feels weak), PYREXIA (Fever), HEADACHE (Headache) and MYALGIA (Muscle ache). At the time of the report, VACCINATION COMPLICATION (Gone down sick), DIZZINESS (Dizzy), ASTHENIA (Feels weak), PYREXIA (Fever), HEADACHE (Headache) and MYALGIA (Muscle ache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment included Ibuprofen. Concomitant medicines taken by the patient  included arthritis pills and cholesterol pills.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: Gone down sick; Dizzy; Feels weak; Fever; Headache; Muscle ache; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Gone down sick), DIZZINESS (Dizzy), ASTHENIA (Feels weak), PYREXIA (Fever) and HEADACHE (Headache) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.     On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Gone down sick), DIZZINESS (Dizzy), ASTHENIA (Feels weak), PYREXIA (Fever), HEADACHE (Headache) and MYALGIA (Muscle ache). At the time of the report, VACCINATION COMPLICATION (Gone down sick), DIZZINESS (Dizzy), ASTHENIA (Feels weak), PYREXIA (Fever), HEADACHE (Headache) and MYALGIA (Muscle ache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment included Ibuprofen. Concomitant medicines taken by the patient  included arthritis pills and cholesterol pills.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Headache, Rash
Clinical narrative: Dizziness; Lightheadedness; Rash; Headaches; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of DIZZINESS (Dizziness), DIZZINESS (Lightheadedness), RASH (Rash) and HEADACHE (Headaches) in a 49-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (Dizziness), DIZZINESS (Lightheadedness), RASH (Rash) and HEADACHE (Headaches). At the time of the report, DIZZINESS (Dizziness), DIZZINESS (Lightheadedness) and HEADACHE (Headaches) had not resolved and RASH (Rash) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medications received by the patient include Ondansetron and meclizine.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Exposure during pregnancy, Vaccination site pain
Clinical narrative: are currently pregnant; sore arm; This spontaneous prospective pregnancy case was reported by a nurse and describes the occurrence of EXPOSURE DURING PREGNANCY (are currently pregnant) and VACCINATION SITE PAIN (sore arm) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by reporter.  Concomitant products included MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) for an unknown indication.    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. The patient's last menstrual period was on an unknown date and the estimated date of delivery was 12-Jun-2021. On 10-Feb-2021, the patient experienced EXPOSURE DURING PREGNANCY (are currently pregnant) and VACCINATION SITE PAIN (sore arm). At the time of the report, EXPOSURE DURING PREGNANCY (are currently pregnant) had resolved and VACCINATION SITE PAIN (sore arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment information was provided. Estimated due date was 12 Jun 2021.
Age: 42.0
Sex: M
Vaccine: COVID19
Symptoms: Skin tightness, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: itchiness at the injection site; swelling at the injection site; tightness of the skin at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of   in a 42-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 057G20A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided. No treatment information provided.   Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: Headaches; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headaches) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 04-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Jan-2021, the patient experienced HEADACHE (Headaches). At the time of the report, HEADACHE (Headaches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided. No treatment information provided.   Reporter did not allow further contact
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Nausea, Pyrexia
Clinical narrative: fever 102F; chills; headache; very nauseous, like I was going to pass out; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (very nauseous, like I was going to pass out), PYREXIA (fever 102F), CHILLS (chills) and HEADACHE (headache) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in July 2020.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced NAUSEA (very nauseous, like I was going to pass out). On 21-Jan-2021, the patient experienced PYREXIA (fever 102F), CHILLS (chills) and HEADACHE (headache). On 22-Jan-2021, NAUSEA (very nauseous, like I was going to pass out), PYREXIA (fever 102F), CHILLS (chills) and HEADACHE (headache) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided. No treatment information provided.   Reporter did not allow further contact
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pruritus, Vaccination site rash
Clinical narrative: Rash; Itch; This spontaneous case was reported by a pharmacist (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE RASH (Rash) and VACCINATION SITE PRURITUS (Itch) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (Itch). On 22-Jan-2021, the patient experienced VACCINATION SITE RASH (Rash). At the time of the report, VACCINATION SITE RASH (Rash) and VACCINATION SITE PRURITUS (Itch) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided. No treatment information provided.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia
Clinical narrative: Numbness on neck, face and arm on side on injection; This spontaneous case was reported by a consumer and describes the occurrence of   in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided. No treatment information provided.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Anosmia, Fatigue, Nasal congestion, Vaccination site pain
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of vaccination site pain (the arm hurts a little), anosmia (lost the sense of smell), nasal congestion (extremely congested) and fatigue (feels really exhausted) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch no. 039K202A) for COVID-19 immunization. Concurrent medical conditions included asthma. On Jan 21, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On Jan 21, 2021, patient experienced vaccination site pain (the arm hurts a little) and fatigue (feels really exhausted). On Jan 22, 2021, patient experienced anosmia (lost the sense of smell) and nasal congestion (extremely congested). At the time of the report, vaccination site pain (the arm hurts a little), anosmia (lost the sense of smell),  nasal congestion (extremely congested) and fatigue (feels really exhausted) outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown. Products known to have been used by the patient, within two weeks prior to the event, included asthma inhaler. Treatment information not provided.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: tested positive for Covid-19; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of COVID-19 (tested positive for Covid-19) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (tested positive for Covid-19). At the time of the report, COVID-19 (tested positive for Covid-19) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   No concomitant medications were provided. No treatment information provided.
Age: 92.0
Sex: F
Vaccine: COVID19
Symptoms: Frequent bowel movements
Clinical narrative: 5 Bowel movement; This spontaneous case was reported by a consumer and describes the occurrence of FREQUENT BOWEL MOVEMENTS (5 Bowel movement) in a 92-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 25J202A) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced FREQUENT BOWEL MOVEMENTS (5 Bowel movement). At the time of the report, FREQUENT BOWEL MOVEMENTS (5 Bowel movement) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided. No treatment information provided.   Reporter did not allow further contact
Sex: U
Vaccine: COVID19
Symptoms: Vaccination site pruritus, Vaccination site rash, Vaccination site warmth
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of vaccination site warmth (warm to the touch at the injection site with itching), vaccination site rash (rash in the injection site) and vaccination site pruritus (warm to the touch at the injection site with itching) in a patient, of an unknown age and gender, who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. On Jan 12, 2021, patient received a dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On Jan 21, 2021, patient experienced vaccination site warmth (warm to the touch at the injection site with itching), vaccination site rash (rash in the injection site) and vaccination site pruritus (warm to the touch at the injection site with itching). At the time of the report, vaccination site warmth (warm to the touch at the injection site with itching), vaccination site rash (rash in the injection site) and vaccination site pruritus (warm to the touch at the injection site with itching) outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown. No concomitant medications or treatment information provided. This case linked to MOD-2021-048030 (patient link).
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Palpitations, Paraesthesia, Regurgitation, Vaccination site pain
Clinical narrative: spitting up clear, thick mucous like liquid; tingling; her heart was racing too; a sore arm; chills; This spontaneous case was reported by a patient (subsequently medically confirmed) and describes the occurrence of REGURGITATION (spitting up clear, thick mucous like liquid), PARAESTHESIA (tingling), PALPITATIONS (her heart was racing too), VACCINATION SITE PAIN (a sore arm) and CHILLS (chills) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     The patient's past medical history included Clotting disorder (Rare blood clotting disorder. diagnosed 20 years back.) and Vertigo (diagnosed 20 years back). Concurrent medical conditions included Allergy (Allergic to latex and oxycontin). Concomitant products included LORATADINE and WARFARIN for an unknown indication.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jan-2021, the patient experienced REGURGITATION (spitting up clear, thick mucous like liquid), PARAESTHESIA (tingling), PALPITATIONS (her heart was racing too), VACCINATION SITE PAIN (a sore arm) and CHILLS (chills). At the time of the report, REGURGITATION (spitting up clear, thick mucous like liquid), PARAESTHESIA (tingling), PALPITATIONS (her heart was racing too), VACCINATION SITE PAIN (a sore arm) and CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema
Clinical narrative: red mark about iron sized on her injection arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (red mark about iron sized on her injection arm) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (red mark about iron sized on her injection arm). At the time of the report, VACCINATION SITE ERYTHEMA (red mark about iron sized on her injection arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided. No treatment information provided.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Myalgia, Pyrexia
Clinical narrative: Uncontrollable chills, tremors; Myalgias; Fatigue; Low-grade fever; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of CHILLS (Uncontrollable chills, tremors), MYALGIA (Myalgias), FATIGUE (Fatigue) and PYREXIA (Low-grade fever) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in April 2020.    On 27-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Dec-2020, the patient experienced CHILLS (Uncontrollable chills, tremors), MYALGIA (Myalgias), FATIGUE (Fatigue) and PYREXIA (Low-grade fever). At the time of the report, CHILLS (Uncontrollable chills, tremors), MYALGIA (Myalgias), FATIGUE (Fatigue) and PYREXIA (Low-grade fever) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication was not reported. Treatment medication was not reported. The patient reported that it was severe, much more severe than when she had COVID19. It lasted for 30 hours.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Eustachian tube dysfunction, Rash, Swollen tongue, Throat irritation
Clinical narrative: scratchy throat/felt like it was burning; eustachian tubes felt like they were clogged; puffy tongue; rash on her throat; This spontaneous case was reported by a consumer and describes the occurrence of THROAT IRRITATION (scratchy throat/felt like it was burning), EUSTACHIAN TUBE DYSFUNCTION (eustachian tubes felt like they were clogged), RASH (rash on her throat) and SWOLLEN TONGUE (puffy tongue) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced THROAT IRRITATION (scratchy throat/felt like it was burning), EUSTACHIAN TUBE DYSFUNCTION (eustachian tubes felt like they were clogged), RASH (rash on her throat) and SWOLLEN TONGUE (puffy tongue). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) on 21-Jan-2021 for Adverse event, at a dose of UNK dosage form and PREDNISONE for Adverse event, at a dose of 50 mg once a day. On 21-Jan-2021, THROAT IRRITATION (scratchy throat/felt like it was burning), EUSTACHIAN TUBE DYSFUNCTION (eustachian tubes felt like they were clogged), RASH (rash on her throat) and SWOLLEN TONGUE (puffy tongue) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not reported. 13 minutes and 47 seconds after the injection while the patient was still in the waiting area, she had a scratchy throat and felt like it was on fire. The patient was brought to the emergency room and was given another Benadryl shot. The reaction abated after 2 hours. She was prescribed with Prednisone 50 mg once a day for five days as home medication. At the time of the call, patient claimed that she was fine.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site warmth
Clinical narrative: hot to the touch, like this arm has fever at the injection site; itching at the injectin site; redness area at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (hot to the touch, like this arm has fever at the injection site), VACCINATION SITE PRURITUS (itching at the injectin site) and VACCINATION SITE ERYTHEMA (redness area at the injection site) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039K20A and 029K20A) for COVID-19 vaccination.     Concurrent medical conditions included Penicillin allergy, Allergy to animals (cats and dogs), Grass allergy and Seafood allergy. Concomitant products included ZINC, ASCORBIC ACID, BIOFLAVONOIDS NOS (VITAMIN C [ASCORBIC ACID;BIOFLAVONOIDS NOS]) and VITAMIN D NOS for Vitamin supplementation, LEVOTHYROXINE SODIUM (SYNTHROID) for an unknown indication.   On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 21-Jan-2021, the patient experienced VACCINATION SITE WARMTH (hot to the touch, like this arm has fever at the injection site), VACCINATION SITE PRURITUS (itching at the injectin site) and VACCINATION SITE ERYTHEMA (redness area at the injection site). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event, at a dose of UNK dosage form. At the time of the report, VACCINATION SITE WARMTH (hot to the touch, like this arm has fever at the injection site), VACCINATION SITE PRURITUS (itching at the injectin site) and VACCINATION SITE ERYTHEMA (redness area at the injection site) outcome was unknown.            The patient did not take any concomitant medication on the day of vaccination and started taking them again the day before the reaction occurred. The patient suspected that it could be interaction between vaccine and iodine in the Synthroid and hence suspended it.   This case was linked to MOD-2021-150632 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 19-May-2021: Reporter address, Allergy, dosage regimen, action taken updated
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Body temperature decreased, Fatigue, Myalgia, Pain in extremity
Clinical narrative: Body aches; fingers were hurting from cold; fingers were hurting from cold; can't call them chills, but her body temperature got really low; feels too weak; broke into a fever and got to 101.4 F; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Body aches), FATIGUE (feels too weak), PERIPHERAL COLDNESS (fingers were hurting from cold), PAIN IN EXTREMITY (fingers were hurting from cold) and PYREXIA (broke into a fever and got to 101.4 F) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced FATIGUE (feels too weak), PERIPHERAL COLDNESS (fingers were hurting from cold), PAIN IN EXTREMITY (fingers were hurting from cold), PYREXIA (broke into a fever and got to 101.4 F) and BODY TEMPERATURE DECREASED (can't call them chills, but her body temperature got really low). On 22-Jan-2021 at 9:15 AM, the patient experienced MYALGIA (Body aches). On 22-Jan-2021, MYALGIA (Body aches), PERIPHERAL COLDNESS (fingers were hurting from cold) and PYREXIA (broke into a fever and got to 101.4 F) had resolved, PAIN IN EXTREMITY (fingers were hurting from cold) outcome was unknown. At the time of the report, FATIGUE (feels too weak) and BODY TEMPERATURE DECREASED (can't call them chills, but her body temperature got really low) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 22-Jan-2021, Body temperature: 101.4 (High) 101.4 degree Fahrenheit.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not reported. Treatment medication was not reported. 15 minutes later to the vaccination, at 7.32, the patient left the clinic and was still good, until 9.15 the day of report, when she got body aches. At 9.40 she experienced "can't call them chills, but her body temperature got really low", her fingers were hurting from cold. At 10.30 she broke into a fever and got to 101.4°F.
Sex: F
Vaccine: COVID19
Symptoms: Peripheral coldness, Pyrexia
Clinical narrative: Body aches; fingers were hurting from cold; fingers were hurting from cold; can't call them chills, but her body temperature got really low; feels too weak; broke into a fever and got to 101.4 F; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Body aches), FATIGUE (feels too weak), PERIPHERAL COLDNESS (fingers were hurting from cold), PAIN IN EXTREMITY (fingers were hurting from cold) and PYREXIA (broke into a fever and got to 101.4 F) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced FATIGUE (feels too weak), PERIPHERAL COLDNESS (fingers were hurting from cold), PAIN IN EXTREMITY (fingers were hurting from cold), PYREXIA (broke into a fever and got to 101.4 F) and BODY TEMPERATURE DECREASED (can't call them chills, but her body temperature got really low). On 22-Jan-2021 at 9:15 AM, the patient experienced MYALGIA (Body aches). On 22-Jan-2021, MYALGIA (Body aches), PERIPHERAL COLDNESS (fingers were hurting from cold) and PYREXIA (broke into a fever and got to 101.4 F) had resolved, PAIN IN EXTREMITY (fingers were hurting from cold) outcome was unknown. At the time of the report, FATIGUE (feels too weak) and BODY TEMPERATURE DECREASED (can't call them chills, but her body temperature got really low) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 22-Jan-2021, Body temperature: 101.4 (High) 101.4 degree Fahrenheit.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not reported. Treatment medication was not reported. 15 minutes later to the vaccination, at 7.32, the patient left the clinic and was still good, until 9.15 the day of report, when she got body aches. At 9.40 she experienced "can't call them chills, but her body temperature got really low", her fingers were hurting from cold. At 10.30 she broke into a fever and got to 101.4°F.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache
Clinical narrative: fatigue; headache; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (fatigue) and HEADACHE (headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced FATIGUE (fatigue) and HEADACHE (headache). On 21-Jan-2021, FATIGUE (fatigue) and HEADACHE (headache) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not reported. Treatment medication was not reported.